FDA Approves New Type of Antibiotic for Gonorrhea, First in Decades

(MedPage Today) — The FDA approved gepotidacin (Blujepa), an oral option for the treatment of uncomplicated urogenital gonorrhea among patients ages 12 years and older, GSK announced on Thursday.
Gepotidacin is the first in a new class of antibiotics…

Source link : https://www.medpagetoday.com/infectiousdisease/stds/118972

Author :

Publish date : 2025-12-11 22:02:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31

FDA Approves New Type of Antibiotic for Gonorrhea, First in Decades

RFK Jr.’s Former Group Urges FDA to Revoke COVID Vax Licenses

Related Posts

RFK Jr.’s Former Group Urges FDA to Revoke COVID Vax Licenses

Florida Sues Medical Groups Over Youth Gender-Affirming Care

Uterine Fibroids Point to Risk of Heart Disease Down the Line

Low Prenatal Vitamin D Linked to Early Cavities in Children

RFK Jr.’s Viral Pull-Ups; Docs Denounce ACIP’s Hep B Vote; ‘Don’t Pee!’

ADC Post-Endocrine Therapy Misses Mark in Advanced Breast Cancer Trial

FDA Approves New Type of Antibiotic for Gonorrhea, First in Decades

RFK Jr.’s Former Group Urges FDA to Revoke COVID Vax Licenses

Florida Sues Medical Groups Over Youth Gender-Affirming Care

Uterine Fibroids Point to Risk of Heart Disease Down the Line

Low Prenatal Vitamin D Linked to Early Cavities in Children

RFK Jr.’s Viral Pull-Ups; Docs Denounce ACIP’s Hep B Vote; ‘Don’t Pee!’

ADC Post-Endocrine Therapy Misses Mark in Advanced Breast Cancer Trial

FDA Proposes Allowing New Sunscreen Ingredient

Categories

Archives